Process of care for carotid endarterectomy: Perioperative medical management

Journal of Vascular Surgery

Volumn 52, Issue 1, 2010, Pages 223-231

  Stoner, Michael C ^a   deFreitas, Dorian J ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; PLACEBO; ROSUVASTATIN; SIMVASTATIN;

ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG DOSE COMPARISON; DRUG MEGADOSE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INCIDENCE; LOW DRUG DOSE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; STROKE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR AGENTS; CAROTID ARTERY DISEASES; ENDARTERECTOMY, CAROTID; EVIDENCE-BASED MEDICINE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL INFARCTION; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77953715748     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.10.125     Document Type: Review

References (78)

1. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 351 (1998) 1379-1387
2. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 325 (1991) 445-453
3. Barnett H.J., Taylor D.W., Eliasziw M., Fox A.J., Ferguson G.G., Haynes R.B., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 339 (1998) 1415-1425
4. Halliday A., Mansfield A., Marro J., Peto C., Peto R., Potter J., et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomized controlled trial. Lancet 363 (2004) 1491-1502
5. Stoner M.C., Abbott W.M., Wong D.R., Hua H.T., Lamuraglia G.M., Kwolek C.J., et al. Defining the high-risk patient for carotid endarterectomy: an analysis of the prospective national surgical quality improvement program database. J Vasc Surg 43 (2006) 285-295 discussion 295-6
6. Kang J.L., Chung T.K., Lancaster R.T., Lamuraglia G.M., Conrad M.F., and Cambria R.P. Outcomes after carotid endarterectomy: is there a high-risk population?. A national surgical quality improvement program report. J Vasc Surg 49 (2009) 331-338 339.e1; discussion 338-9
7. Matsen S.L., Perler B.A., and Chang D.C. A preliminary clinical scale to predict the risk of in-hospital death after carotid endarterectomy. J Vasc Surg 42 (2005) 861-868 discussion 869
8. Bunch C.T., and Kresowik T.F. Can randomized trial outcomes for carotid endarterectomy be achieved in community-wide practice?. Semin Vasc Surg 17 (2004) 209-213
9. Eastcott H.H., Pickering G.W., and RobB C.G. Reconstruction of internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet 267 (1954) 994-996
10. Debakey M.E., Crawford E.S., Cooley D.A., Morris Jr. G.C., Garrret H.E., and Fields W.S. Cerebral arterial insufficiency: one to 11-year results following arterial reconstructive operation. Ann Surg 161 (1965) 921-945
11. Rubio P.A., and Guinn G.A. Myocardial infarction following carotid endarterectomy. Cardiovasc Dis 2 (1975) 402-404
12. Robertson J.T. Carotid endarterectomy: a saga of clinical science, personalities, and evolving technology: the Willis lecture. Stroke 29 (1998) 2435-2441
13. Mackey W.C., O'Donnell Jr. T.F., and Callow A.D. Cardiac risk in patients undergoing carotid endarterectomy: impact on perioperative and long-term mortality. J Vasc Surg 11 (1990) 226-233 discussion 233-4
14. Hertzer N.R., Beven E.G., Young J.R., O'Hara P.J., Ruschhaupt W.F.I., Graor R.A., et al. Coronary artery disease in peripheral vascular patients: a classification of 1000 coronary angiograms and results of surgical management. Ann Surg 199 (1984) 223-233
15. Hertzer N.R., Young J.R., Beven E.G., Graor R.A., O'Hara P.J., Ruschhaupt III W.F., et al. Coronary angiography in 506 patients with extracranial cerebrovascular disease. Arch Intern Med 145 (1985) 849-852
16. LaMuraglia G.M., Brewster D.C., Moncure A.C., Dorer D.J., Stoner M.C., Trehan S.K., et al. Carotid endarterectomy at the millennium: what interventional therapy must match. Ann Surg 240 (2004) 535-544 discussion 544-6
17. Sidawy A.N., Zwolak R.M., White R.A., Siami F.S., Schermerhorn M.L., Sicard G.A., et al. Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS vascular registry. J Vasc Surg 49 (2009) 71-79
18. Yadav J.S., Wholey M.H., Kuntz R.E., Fayad P., Katzen B.T., Mishkel G.J., et al. Protected carotid-artery stenting vs endarterectomy in high-risk patients. N Engl J Med 351 (2004) 1493-1501
19. Boucher C.A., Brewster D.C., Darling R.C., Okada R.D., Strauss H.W., and Pohost G.M. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med 312 (1985) 389-394
20. Riles T.S., Kopelman I., and Imparato A.M. Myocardial infarction following carotid endarterectomy: a review of 683 operations. Surgery 85 (1979) 249-252
21. Yeager R.A., Moneta G.L., McConnell D.B., Neuwelt E.A., Taylor Jr. L.M., and Porter J.M. Analysis of risk factors for myocardial infarction following carotid endarterectomy. Arch Surg 124 (1989) 1142-1145
22. Krupski W.C. Myocardial revascularization before carotid endarterectomy. J Cardiovasc Surg (Torino) 44 (2003) 371-382
23. McFalls E.O., Ward H.B., Moritz T.E., Goldman S., Krupski W.C., Littooy F., et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351 (2004) 2795-2804
24. Durand D.J., Perler B.A., Roseborough G.S., Grega M.A., Borowicz Jr. L.M., Baumgartner W.A., et al. Mandatory vs selective preoperative carotid screening: A retrospective analysis. Ann Thorac Surg 78 (2004) 159-166 discussion 159-66
25. Naylor A.R. Does the risk of post-CABG stroke merit staged or synchronous reconstruction in patients with symptomatic or asymptomatic carotid disease?. J Cardiovasc Surg (Torino) 50 (2009) 71-81
26. Fleisher L.A., Beckman J.A., Brown K.A., Calkins H., Chaikof E.L., Fleischmann K.E., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular angiography and interventions, society for vascular medicine and biology, and society for vascular surgery. J Am Coll Cardiol 50 (2007) 1707-1732
27. Poldermans D., Boersma E., Bax J.J., Thomson I.R., van de Ven L.L., Blankensteijn J.D., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. N Engl J Med 341 (1999) 1789-1794
28. Frishman W.H. Beta-adrenergic blockers: a 50-year historical perspective. Am J Ther 15 (2008) 565-576
29. Mangano D.T., Layug E.L., Wallace A., and Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter study of perioperative ischemia research group. N Engl J Med 335 (1996) 1713-1720
30. POISE Study Group, Devereaux P.J., Yang H., Yusuf S., Guyatt G., Leslie K., et al. Effects of extended-release metoprolol succinate in patients undergoing noncardiac surgery (POISE trial): a randomized controlled trial. Lancet 371 (2008) 1839-1847
31. Bangalore S., Wetterslev J., Pranesh S., Sawhney S., Gluud C., and Messerli F.H. Perioperative beta-blockers in patients having noncardiac surgery: a meta-analysis. Lancet 372 (2008) 1962-1976
32. Skeggs Jr. L.T., Kahn J.R., and Shumway N.P. The preparation and function of the hypertensin-converting enzyme. J Exp Med 103 (1956) 295-299
33. Hobbs S.D., Thomas M.E., and Bradbury A.W. Manipulation of the renin angiotensin system in peripheral arterial disease. Eur J Vasc Endovasc Surg 28 (2004) 573-582
34. Rice T.W., and Lumsden A.B. Optimal medical management of peripheral arterial disease. Vasc Endovasc Surg 40 (2006) 312-317
35. Fukuhara M., Geary R.L., Diz D.I., Gallagher P.E., Wilson J.A., Glazier S.S., et al. Angiotensin-converting enzyme expression in human carotid artery atherosclerosis. Hypertension 35 1 Pt 2 (2000) 353-359
36. Mukherjee D., and Yadav J.S. Carotid artery intimal-medial thickness: indicator of atherosclerotic burden and response to risk factor modification. Am Heart J 144 (2002) 753-759
37. Sattler K.J., Woodrum J.E., Galili O., Olson M., Samee S., Meyer F.B., et al. Concurrent treatment with renin-angiotensin system blockers and acetylsalicylic acid reduces nuclear factor κB activation and C-reactive protein expression in human carotid artery plaques. Stroke 36 (2005) 14-20
38. Ostergren J., Sleight P., Dagenais G., Danisa K., Bosch J., Qilong Y., et al. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 25 (2004) 17-24
39. Smith Jr. S.C., Blair S.N., Bonow R.O., Brass L.M., Cerqueira M.D., Dracup K., et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 38 (2001) 1581-1583
40. Stancu C., and Sima A. Statins: mechanism of action and effects. J Cell Mol Med 5 (2001) 378-387
41. Vaughan C.J., Gotto Jr. A.M., and Basson C.T. The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 35 (2000) 1-10
42. Conde K., Vergara-Jimenez M., Krause B.R., Newton R.S., and Fernandez M.L. Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig. J Lipid Res 37 (1996) 2372-2382
43. Bellosta S., Ferri N., Bernini F., Paoletti R., and Corsini A. Non-lipid-related effects of statins. Ann Med 32 (2000) 164-176
44. McKenney J.M., Jones P.H., Adamczyk M.A., Cain V.A., Bryzinski B.S., Blasetto J.W., et al. Comparison of the efficacy of rosuvastatin vs atorvastatin, simvastatin, and pravastatin in achieving lipid goals: Results from the STELLAR trial. Curr Med Res Opin 19 (2003) 689-698
45. Molloy K.J., Thompson M.M., Schwalbe E.C., Bell P.R., Naylor A.R., and Loftus I.M. Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on vs not on statins preoperatively. Am J Cardiol 94 (2004) 144-146
46. Koh K.K. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res 47 (2000) 648-657
47. Rosenson R.S., and Tangney C.C. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 279 (1998) 1643-1650
48. Schwartz G.G., Olsson A.G., Ezekowitz M.D., Ganz P., Oliver M.F., Waters D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: a randomized controlled trial. JAMA 285 (2001) 1711-1718
49. Pan W., Pintar T., Anton J., Lee V.V., Vaughn W.K., and Collard C.D. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 110 11 Suppl 1 (2004) II45-II49
50. Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360 (2002) 7-22
51. O'Neil-Callahan K., Katsimaglis G., Tepper M.R., Ryan J., Mosby C., Ioannidis J.P., et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the statins for risk reduction in surgery (StaRRS) study. J Am Coll Cardiol 45 (2005) 336-342
52. Durazzo A.E., Machado F.S., Ikeoka D.T., De Bernoche C., Monachini M.C., Puech-Leao P., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 (2004) 967-975 discussion 975-6
53. Goldstein L.B., Amarenco P., Lamonte M., Gilbert S., Messig M., Callahan A., et al. Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. Stroke 39 (2008) 2444-2448
54. Amarenco P., Benavente O., Goldstein L.B., Callahan III A., Sillesen H., Hennerici M.G., et al. Results of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial by stroke subtypes. Stroke (2009)
55. Amarenco P., Labreuche J., Lavallee P., and Touboul P.J. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke 35 (2004) 2902-2909
56. O'Regan C., Wu P., Arora P., Perri D., and Mills E.J. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients. Am J Med 121 (2008) 24-33
57. Kennedy J., Quan H., Buchan A.M., Ghali W.A., and Feasby T.E. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 36 (2005) 2072-2076
58. McGirt M.J., Perler B.A., Brooke B.S., Woodworth G.F., Coon A., Jain S., et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 42 (2005) 829-836 discussion 836-7
59. LaMuraglia G.M., Stoner M.C., Brewster D.C., Watkins M.T., Juhola K.L., Kwolek C., et al. Determinants of carotid endarterectomy anatomic durability: effects of serum lipids and lipid-lowering drugs. J Vasc Surg 41 (2005) 762-768
60. Stoner M.C., Cambria R.P., Brewster D.C., Juhola K.L., Watkins M.T., Kwolek C.J., et al. Safety and efficacy of reoperative carotid endarterectomy: a 14-year experience. J Vasc Surg 41 (2005) 942-949
61. Betancourt M., Van Stavern R.B., Share D., Gardella P., Martus M., and Chaturvedi S. Are patients receiving maximal medical therapy following carotid endarterectomy?. Neurology 63 (2004) 2011-2015
62. Riles T.S., Imparato A.M., Jacobowitz G.R., Lamparello P.J., Giangola G., Adelman M.A., et al. The cause of perioperative stroke after carotid endarterectomy. J Vasc Surg 19 (1994) 206-214 discussion 215-6
63. Gaunt M.E., Smith J.L., Ratliff D.A., Bell P.R., and Naylor A.R. A comparison of quality control methods applied to carotid endarterectomy. Eur J Vasc Endovasc Surg 11 (1996) 4-11
64. Lennard N., Smith J., Dumville J., Abbott R., Evans D.H., London N.J., et al. Prevention of postoperative thrombotic stroke after carotid endarterectomy: the role of transcranial Doppler ultrasound. J Vasc Surg 26 (1997) 579-584
65. Stratton J.R., Zierler R.E., and Kazmers A. Platelet deposition at carotid endarterectomy sites in humans. Stroke 18 (1987) 722-727
66. Lennard N., Smith J.L., Hayes P., Evans D.H., Abbott R.J., London N.J., et al. Transcranial Doppler directed dextran therapy in the prevention of carotid thrombosis: three hour monitoring is as effective as six hours. Eur J Vasc Endovasc Surg 17 (1999) 301-305
67. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
68. A randomised, blinded, trial of clopidogrel vs aspirin in patients at risk of ischemic events (CAPRIE). CAPRIE steering committee. Lancet 348 (1996) 1329-1339
69. Diener H.C., Bogousslavsky J., Brass L.M., Cimminiello C., Csiba L., Kaste M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
70. Lindblad B., Persson N.H., Takolander R., and Bergqvist D. Does low-dose acetylsalicylic acid prevent stroke after carotid surgery?. A double-blind, placebo-controlled randomized trial. Stroke 24 (1993) 1125-1128
71. Boysen G., Sorensen P.S., Juhler M., Andersen A.R., Boas J., Olsen J.S., et al. Danish very-low-dose aspirin after carotid endarterectomy trial. Stroke 19 (1988) 1211-1215
72. Taylor D.W., Barnett H.J., Haynes R.B., Ferguson G.G., Sackett D.L., Thorpe K.E., et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomized controlled trial. ASA and carotid endarterectomy (ACE) trial collaborators. Lancet 353 (1999) 2179-2184
73. American College of Chest Physicians, American College of Chest Physicians, Sobel M., and Verhaeghe R. Antithrombotic therapy for peripheral artery occlusive disease: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 133 6 Suppl (2008) 815S-843S
74. Payne D.A., Jones C.I., Hayes P.D., Thompson M.M., London N.J., Bell P.R., et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation 109 (2004) 1476-1481
75. Engelter S., and Lyrer P. Antiplatelet therapy for preventing stroke and other vascular events after carotid endarterectomy. Stroke 35 (2004) 1227-1228
76. Goodney P.P., Likosky D.S., Cronenwett J.L., and Vascular Study Group of Northern New England. Factors associated with stroke or death after carotid endarterectomy in northern New England. J Vasc Surg 48 (2008) 1139-1145
77. Kresowik T.F., Bratzler D.W., Kresowik R.A., Hendel M.E., Grund S.L., Brown K.R., et al. Multistate improvement in process and outcomes of carotid endarterectomy. J Vasc Surg 39 (2004) 372-380
78. Assadian A., Eidher U., Senekowitsch C., Rotter R., Lochli S., Hagmuller G.W., et al. Antiplatelet therapy prior to carotid endarterectomy-still room for improvement. Vasa 35 (2006) 96-100